Renú® calcium hydroxylapatite (CaHA) implant is indicated as a soft tissue bulking agent for subdermal implantation to correct moderate to severe facial wrinkles, folds, and for the restoration or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV).
Renú® CaHA soft tissue filler implant is a sterile, semi-solid, cohesive implant. The semi-sold nature is created by suspending the CaHA particles in a durable high-yield strength thixotropic gel. The aqueous phosphate buffer gel carrier consists of sodium carboxymethylcellulose (NaCMC) and glycerin. The carrier resorbs in vivo, so that the CaHA remains at the site of implantation, providing a scaffold for local tissue infiltration. This cellular infiltrated CaHA scaffold provides the long-term, non-permanent restoration and augmentation. Over time, the tiny micro-particles gradually break down into calcium and phosphate ions that are naturally absorbed by the body.
Renú® is a dermal filler used for facial aesthetic enhancement and beautification. Renú® uses advanced CaHA based technology to provide longer-lasting result.
- Renú® does more than just fill facial wrinkles and folds such as nasolabial folds. Its advanced calcium-based technology promotes the growth of a patient’s own collagen to create fullness and a youthful appearance by restoring volume. This creates a youthful appearance with results that last longer than other fillers.
- Renú® provides an aesthetic correction that has been shown to last a year or longer without the risks associated with permanent implants.